Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about KDM5C: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
KDM5C is a gene implicated in neurodegeneration research. Key relationships include: activates, implicated in. Associated with Als, Cancer, Glioblastoma. Connected to 12 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | KDM5C |
| Full Name | Lysine Demethylase 5C |
| Chromosome | Xp11.22 |
| Function | encodes an X-linked JmjC domain-containing histone demethylase that removes di- and trimethyl marks from histone H3 lysine 4 (H3K4me2/3). |
| Amino Acids | 1560 aa |
| Pathways | Epigenetic, epigenetic regulation |
| UniProt ID | [P41229](https://www.uniprot.org/uniprot/P41229) |
| Ensembl ID | ENSG00000126012 |
| GeneCards | KDM5C |
| Human Protein Atlas | KDM5C |
| JmjN + JmjC domains | Catalytic domains for Fe(II)/2-OG-dependent oxidative demethylation of H3K4me2/3 |
| ARID domain | AT-rich interaction domain for DNA binding, directing KDM5C to specific genomic loci |
| PHD fingers (2x) | PHD1 reads H3K9me3, linking KDM5C to heterochromatin; PHD2 reads unmethylated H3K4, providing product recognition |
| C5HC2 zinc finger | Mediates interactions with transcriptional co-repressors including REST/NRSF and HDAC complexes |
| Enhancer decommissioning | KDM5C removes H3K4me3 from deactivating enhancers, converting them to poised (H3K4me1) state. Loss of KDM5C causes persistent "ghost" enhancers that drive spurious gene expression |
| Associated Diseases | neurodegeneration |
| Interactions | CANCER, EGFR, ERK1, GABPA, MYC, TERT |
| KG Connections | 12 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
KDM5C["KDM5C"]
Als{"Als"}
KDM5C -->|"activates"| Als
Cancer{"Cancer"}
KDM5C -->|"activates"| Cancer
Tumor{"Tumor"}
KDM5C -->|"activates"| Tumor
Glioblastoma{"Glioblastoma"}
KDM5C -->|"activates"| Glioblastoma
MYC["MYC"]
KDM5C -->|"activates"| MYC
EGFR["EGFR"]
KDM5C -->|"activates"| EGFR
CANCER["CANCER"]
KDM5C -->|"activates"| CANCER
ERK1["ERK1"]
KDM5C -->|"activates"| ERK1
TERT["TERT"]
KDM5C -->|"activates"| TERT
GABPA["GABPA"]
KDM5C -->|"activates"| GABPA
Epigenetic(["Epigenetic"])
KDM5C -->|"activates"| Epigenetic
neurodegeneration["neurodegeneration"]
KDM5C -->|"implicated in"| neurodegeneration
style KDM5C fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| TERT | activates | gene | 0.60 |
| GABPA | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| epigenetic regulation | participates_in | pathway | 0.60 |
| Epigenetic | activates | pathway | 0.60 |
| MYC | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| ERK1 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning KDM5C in their description or question text
No additional research found